The cost-effectiveness of screening for latent tuberculosis infection.
Taylor
Z
Z
Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. zxt0@cdc.gov
D000293:Adolescent; D000328:Adult; D000368:Aged; D000995:Antitubercular Agents / Q000191:economics* / Q000627:therapeutic use; D002648:Child; D003362:Cost-Benefit Analysis; D003663:Decision Trees; D005260:Female; D006801:Humans; D008297:Male; D008390:Markov Chains; D008403:Mass Screening / Q000191:economics*; D008875:Middle Aged; D017059:Models, Econometric; D019057:Quality-Adjusted Life Years; D014376:Tuberculosis / Q000191:economics / Q000517:prevention & control*; D014481:United States
D000995:Antitubercular Agents